CHICAGO, June 26, 2020
CHICAGO, June 26, 2020 /PRNewswire/ -- According to the new market research report "Aseptic Sampling Market by Type (Manual [Type (Traditional, Single-use), Product (Bags, Bottles, Syringes, Accessories)], Automatic), Application (Upstream, Downstream), Technique (Off-line, On-line), End User (R&D, CMO, CRO) - Global Forecast to 2025", published by MarketsandMarkets™, the Aseptic Sampling Market is projected to grow at a CAGR of 12.4% during the forecast period to reach USD 474 million by 2025 from USD 264 million in 2020.
Download PDF Brochure:
Factors such as the increasing demand for biopharmaceuticals, stringent government regulations to ensure drug safety, and funding to support life sciences research activities are driving the growth of this market.
The off-line technique segment accounted for the largest share of the aseptic sampling market.
Based on the technique, the aseptic sampling market is segmented into off-line, at-line, and on-line technologies. The off-line segment accounted for the largest share of the aseptic sampling market in 2019. Off-line sample collection is a traditional and widely used method of collecting samples aseptically, which is the primary factor responsible for the large share of this market segment.
Browse in-depth TOC on "Aseptic Sampling Market"
158 – Tables
29 – Figures
138 – Pages
The upstream processessegment accounted for the largest share of the aseptic sampling market in 2019.
Based on the application, the aseptic sampling market is segmented into p into upstream processes and downstream processes. In 2019, the upstream processes segment dominated this market.Being the start of bioproduction, upstream processes form a key application area for aseptic sampling. Any contamination originating from the upstream process will be carried to the following procedures and affect overall production, leading to failure. Their importance in this stage is the key factor supporting the use of aseptic sampling products.
Europe dominate the aseptic sampling market during the forecast period
In 2019, Europe dominated the aseptic samplingmarket, followed by Europe. The major factors driving the growth of this market include the patent cliff of several biologic drugs in the region. As a result, several companies in Europe are engaged in research activities for the development of novel drug products. In addition to this, governments in several European countries are supporting pharmaceutical companies to launch new biologic therapies that offer superior efficacy than traditional drugs. This, in turn, is increasing the number of R&D activities in the region and supporting the uptake of aseptic sampling products.
Get 10% Customization on this Research Report:
The prominent players in this market include Sartorius Stedim Biotech (France), Merck Millipore (Germany), Danaher Corporation (US), and Thermo Fisher Scientific (US). Other key players include Saint-Gobain (France), GEA Group (Germany), Avantor, Inc. (US), QualiTru Sampling Systems (US), Keofitt (Denmark), GEMÜ Group (US), W. L. Gore & Associates (US), Flownamics Analytical Instruments, Inc. (US), Lonza (Switzerland), and Trace Analytics (US).
Browse Adjacent Markets: Biotechnology Market Research Reports & Consulting
Get Special Pricing on Bundle Reports: https://www.marketsandmarkets.com/RequestBundleReport.asp?id=9034729
Browse Related Reports:
Downstream Processing Market by Technique (Separation, Concentration, Purification), Product (Chromatography Column & Resin, Filter, Single use), Application (Mab Production), End User (Contract Manufacturing Organization) - Global Forecast to 2021
Single-use Bioprocessing Market by Product (Single-use Media Bags and Containers, Single-use Bioreactor, Filtration Assemblies), Application (Cell Culture, Purification), End User (Life Science R&D, Biopharmaceutical Manufacturer) - Global Forecast to 2021
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Mr. Aashish Mehra
630 Dundee Road
Northbrook, IL 60062
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/aseptic-sampling-market.asp
Visit Our Website: https://www.marketsandmarkets.com
Content Source: https://www.marketsandmarkets.com/PressReleases/aseptic-sampling.asp